Biotechnology
Technology
Health

Acceleron Pharma

$41.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (0.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell XLRN and other stocks, options, ETFs, and crypto commission-free!

About XLRN

Acceleron Pharma Inc. Common Stock, also called Acceleron Pharma, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Read More Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maneates in June 2003 and is headquartered in Cambridge, MA.

Employees
173
Headquarters
Cambridge, Massachusetts
Founded
2003
Market Cap
2.15B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
388.79K
High Today
$41.70
Low Today
$40.48
Open Price
$41.10
Volume
198.90K
52 Week High
$59.59
52 Week Low
$37.01

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Therapy
Pharmaceutical
2013 IPO
US

XLRN Earnings

-$0.75
-$0.69
-$0.64
-$0.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.